Market Overview

Eagle Pharmaceuticals, Inc. to Present at Jefferies 2017 London Healthcare Conference

Share:

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) ("Eagle" or "the Company")
today announced that Scott Tarriff, Chief Executive Officer, will
present at the Jefferies 2017 London Healthcare Conferences as follows:

     
Date: Wednesday, November 15, 2017
Time: 8:00 a.m. Greenwich Mean Time
Location: The Waldorf Hilton, Aldwych, London, UK

Webcast:

http://wsw.com/webcast/jeff108/egrx/

 

The presentation will be webcast live at the aforementioned time, and
archived for 30 days thereafter, via the Company's website at www.eagleus.com,
under the Investors Section.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and
commercializing injectable products that address the shortcomings, as
identified by physicians, pharmacists and other stakeholders, of
existing commercially successful injectable products. Eagle's strategy
is to utilize the FDA's 505(b)(2) regulatory pathway. Additional
information is available on the Company's website at www.eagleus.com.

View Comments and Join the Discussion!